Skip to main content

NOTICE: Due to a lapse in annual appropriations, most of this website is not being updated. Learn more.

Form submissions will still be accepted but will not receive responses at this time. Sections of this site for programs using non-appropriated funds (such as NVLAP) or those that are excepted from the shutdown (such as CHIPS and NVD) will continue to be updated.

U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Quantitative Bright-Field Microscopy Combined with Deep Neural Networks Predict Live Tissue Function

Published

Author(s)

Carl Simon, Nicholas J. Schaub, Petru S. Manescu, Sarala Padi, Mylene Simon, Peter Bajcsy, Nathan A. Hotaling, Joe Chalfoun, Mohamed Ouladi, Qin Wan, Kapil Bharti, Ruchi Sharma

Abstract

Progressive increases in the number of cell therapies in the preclinical and clinical phases has prompted the need for reliable and non-invasive assays to validate transplant function in clinical biomanufacturing. Here, we developed a robust characterization platform composed of quantitative bright- field absorbance microscopy (QBAM) and deep neural networks (DNNs) to non-invasively predict tissue function and cellular donor identity. The platform was validated using clinical-grade induced pluripotent stem cell derived retinal pigment epithelial cells (iRPE). QBAM images of iRPE were used to train DNNs that predicted iRPE monolayer transepithelial resistance (R2=0.97), predicted polarized VEGF secretion (R2=0.89), and matched iRPE monolayers to the iPSC donors (accuracy=85%). DNN predictions were supplemented with traditional machine learning algorithms that identified shape and texture features of single cells that were used to predict tissue function and iPSC donor identity. These results demonstrate non-invasive cell therapy characterization can be achieved with quantitative bright-field microscopy and machine learning.
Citation
Biomaterials

Keywords

deep neural networks, induced pluripotent stem cells, retinal pigment epithelial cells, bright-field microscopy, machine learning, cell therapy

Citation

Simon, C. , Schaub, N. , Manescu, P. , Padi, S. , Simon, M. , Bajcsy, P. , Hotaling, N. , Chalfoun, J. , Ouladi, M. , Wan, Q. , Bharti, K. and Sharma, R. (2020), Quantitative Bright-Field Microscopy Combined with Deep Neural Networks Predict Live Tissue Function, Biomaterials, [online], https://doi.org/10.1172/JCI131187, https://tsapps.nist.gov/publication/get_pdf.cfm?pub_id=926975 (Accessed October 13, 2025)

Issues

If you have any questions about this publication or are having problems accessing it, please contact [email protected].

Created February 29, 2020, Updated September 29, 2025
Was this page helpful?